A pharmaceutical solution suitable for oral administration containing an effective amount of Imatinib including its pharmaceutically acceptable salts and polymorphs such as [alpha], [beta] or [alpha]2 to improve the dosage uniformity, palatability and thus patient compliance. The invention also relates to a process for the preparation of stable aqueous oral formulation that can be swallowed easily and comprising active ingredient in an effective concentration for the better therapy especially fo...

The invention provides a pharmaceutical combination comprising: a) a pyrimidylaminobenzamide compound and b) imatinib. and a method for treating or preventing a proliferative disease especially GIST using such a combination.